Janssen Sues Teva To Stop Generic Of Schizophrenia Drug
A generic version of the schizophrenia drug Invega Sustenna that Teva Pharmaceuticals seeks to manufacture and sell would infringe the asserted claims of a patent covering the drug, Janssen Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article